1. Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory Divide

   • Andrew J. Krentz
   • Ken Fujioka
   • Marcus Hompesch

   Editorial 12 May 2015 Pages: 931 - 933

2. The New Era of Drug Therapy for Obesity: The Evidence and the Expectations

   • Ben J. Jones
   • Stephen R. Bloom

   Leading Article Open access 19 May 2015 Pages: 935 - 945

   

3. Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis

   • Heinz Wiendl
   • Sven G. Meuth

   Leading Article Open access 02 June 2015 Pages: 947 - 977

   

4. Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice

   • Julie Kalabalik
   • Gail B. Rattinger
   • Anastasia Rivkin

   Review Article 22 May 2015 Pages: 979 - 998

   

5. Management Strategies for Clopidogrel Hypersensitivity

   • Craig J. Beavers
   • Nicolas W. Carris
   • Kathryn M. Ruf

   Review Article 09 June 2015 Pages: 999 - 1007

   

6. Regorafenib: A Review of Its Use in Patients with Advanced Gastrointestinal Stromal Tumours

   • Matt Shirley
   • Gillian M. Keating

   Adis Drug Evaluation 22 May 2015 Pages: 1009 - 1017

   

7. Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique^®): A Review of Its Use as an Oral Contraceptive

   • Celeste B. Burness

   Adis Drug Evaluation 28 May 2015 Pages: 1019 - 1026

   

8. Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir: A Review in Chronic HCV Genotype 1 Infection

   • Emma D. Deeks

   Adis Drug Evaluation 10 June 2015 Pages: 1027 - 1038

   

9. Pasireotide in Acromegaly: A Review

   • Kate McKeage

   Adis Drug Evaluation 28 May 2015 Pages: 1039 - 1048